Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 December, 2018 19:24 IST
USFDA completes inspection of Lupin's Mandideep location
Source: IRIS | 05 Dec, 2018, 03.31PM
Comments  |  Post Comment

Pharma major Lupin announced today the completion of United States Food and Drug Administration (US FDA) inspections carried out at its Mandideep location. Lupin's Mandideep location houses the company's cardiovascular ''Pril'' API facilities, Cephalosporin API facilities and Cephalosporin Solid Oral Dosage Form facility. These inspections were carried out between November 26 and December 4, 2018.

The inspection at Unit-2, the Cardiovascular ''Pril'' API facilities closed with 4 observations.

The inspection at Unit-1, the Cephalosporin facilities closed with 10 observations for the Cephalosporin API facilities and 8 observations for the Cephalosporin Solid Oral Dosage Form facility.

The observations are largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API block and the company is confident of addressing them satisfactorily. 

As a company,  Lupin has committed to an enhanced Quality Management System and Compliance Sustainability Plan.  The Lupin Mandideep site is already executing the plan, which also serves to address some of the concerns raised during this inspection.

There are no new DMF and ANDA applications pending for review or approval from Lupin's Mandideep facilities.

Shares of the company declined Rs 28.95, or 3.26%, to trade at Rs 859.10. The total volume of shares traded was 171,672 at the BSE (3.23 p.m., Wednesday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Commercial Engg & Body Builders Co bags order worth Rs 1.52 bn - 19-Dec-2018 10:51
Glenmark Pharma forays into dermatology segment in U.S - 19-Dec-2018 10:33
Power Mech Projects wins orders worth Rs 2.45 bn - 18-Dec-2018 10:42
M&M to hike stake in associate company Sampo Rosenlew - 18-Dec-2018 10:37
Glenmark Pharma gets nod for Fluocinolone Acetonide oil - 18-Dec-2018 10:08
BGR Energy Systems bags order worth Rs 494 mn from Tamilnadu Transmission Corp - 18-Dec-2018 10:04
Lupin receives approval from USFDA for Clobazam tablets - 18-Dec-2018 10:01
Ahluwalia Contracts (India) secures new order worth RS 4.25 bn - 17-Dec-2018 15:31
Lupin receives tentative USFDA approval for Tadalafil tablets - 17-Dec-2018 14:49
Gayatri Projects bags new order worth Rs 4.93 bn - 17-Dec-2018 09:43
Zydus Cadila receives USFDA approvals for two drugs - 17-Dec-2018 09:39
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer